Keywords: morphosys, gets, first, ab, milestone, novartis, german

Morphosys gets first Ab milestone from Novartis

Article | 15 August 2005

Print This

German company MorphoSys AG has finished its first therapeutic antibody program undertaken together with Swiss drug major Novartis.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in